Offer Update
20 11월 2009 - 3:22AM
UK Regulatory
TIDMCSRT TIDMMLH
RNS Number : 8203C
Consort Medical PLC
19 November 2009
+----------------------------------------------------+------------------------+
| PRESS ANNOUNCEMENT |
+-----------------------------------------------------------------------------+
| FOR IMMEDIATE RELEASE |
+-----------------------------------------------------------------------------+
| 19 NOVEMBER 2009 | |
| | |
+----------------------------------------------------+------------------------+
| CONSORT MEDICAL PLC AND THE MEDICAL HOUSE PLC |
| |
+-----------------------------------------------------------------------------+
| RECOMMENDED CASH OFFER OF 27.5 PENCE PER SHARE |
| BY |
| CONSORT MEDICAL PLC |
| FOR |
| THE MEDICAL HOUSE PLC |
| COMPULSORY acquisition, cancellation of admission of the medical house plc |
| shares to trading on AIM and re-registration |
| |
+----------------------------------------------------+------------------------+
+------------------+---------------------------------------------------------+
| Compulsory acquisition |
| On 5 November 2009, Consort Medical announced that its recommended cash |
| offer (with a Loan Notes Alternative) for the entire issued and to be |
| issued share capital of The Medical House was declared unconditional in |
| all respects. The Consort Medical Board announces that it has now received |
| sufficient acceptances under the Offer, and acquired sufficient The |
| Medical House Shares, to apply the provisions of sections 974 to 991 of |
| the Companies Act to acquire compulsorily any outstanding The Medical |
| House Shares to which the Offer relates. |
| Accordingly, compulsory acquisition notices will be despatched shortly to |
| The Medical House Shareholders who have not yet validly accepted the |
| Offer. |
| Cancellation of admission of The Medical House Shares to trading on AIM |
| Consort Medical has requested The Medical House to make an application to |
| cancel the admission of The Medical House Shares to trading on AIM. This |
| cancellation will significantly reduce the liquidity and marketability of |
| any The Medical House Shares not acquired pursuant to the Offer. |
| The Medical House announced earlier today that it has made an application |
| to the London Stock Exchange for the cancellation of the admission to |
| trading on AIM and that the cancellation will take effect on 18 December |
| 2009. |
| Re-registration of The Medical House as a private company |
| Furthermore, it is intended that in due course The Medical House will seek |
| to be re-registered as a private company under the relevant provisions of |
| the Companies Act. |
| Acceptance of the Offer |
| The Offer, which remains subject to the terms and conditions set out in |
| the Offer Document and the Form of Acceptance will remain open for |
| acceptance until further notice. The Medical House Shareholders who have |
| not yet accepted the Offer are urged to do so as soon as possible. |
| The Medical House Shareholders who have not yet accepted the Offer and who |
| hold The Medical House Shares in certificated form are urged to complete, |
| sign and return the Form(s) of Acceptance by hand (during normal business |
| hours) or by post as soon as possible to Capita Registrars at Corporate |
| Actions, The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU. |
| Additional Forms of Acceptance are available from Capita Registrars, by |
| telephoning 0870 162 3121 or, if calling from outside the UK, on +44 208 |
| 639 3399. If you hold your The Medical House Shares in uncertificated form |
| (that is, in CREST) you are urged to accept the Offer by TTE Instructions |
| as soon as possible. |
| Save as disclosed above, neither Consort Medical nor any person acting in |
| concert with Consort Medical for the purposes of the Offer is interested |
| in or has any rights to subscribe for any The Medical House Shares nor |
| does any such person have any short position or any arrangement in |
| relation to The Medical House Shares. For these purposes "arrangement" |
| includes any agreement to sell or any dealing obligation or right to |
| require another person to purchase or take delivery of, and borrowing or |
| lending of, The Medical House Shares. An "arrangement" also includes any |
| indemnity or option arrangement, any agreement or understanding, formal or |
| informal, of whatever nature, relating to The Medical House Shares which |
| may be an inducement to deal or refrain from dealing in such securities. |
| "Interest" includes any long economic exposure, whether conditional or |
| absolute, to changes in the price of securities and a person is treated as |
| having an "interest" by virtue of the ownership or control of securities, |
| or by virtue of any option in respect of, or derivative referenced to |
| securities. |
| Settlement of the consideration due under the Offer in respect of further |
| acceptances which are valid and complete in all respects, will be |
| despatched within 14 days of receipt. |
| Terms used in this announcement shall have the meaning given to them in |
| the Offer Document dated 24 September 2009, unless the context requires |
| otherwise. |
| |
+----------------------------------------------------------------------------+
| Enquiries |
+----------------------------------------------------------------------------+
| For further information please contact: |
+----------------------------------------------------------------------------+
| | |
+------------------+---------------------------------------------------------+
| Consort Medical | |
+------------------+---------------------------------------------------------+
| Jonathan Glenn | +44 (0)1442 867 920 |
+------------------+---------------------------------------------------------+
| Toby Woolrych | www.consortmedical.com |
+------------------+---------------------------------------------------------+
| | |
+------------------+---------------------------------------------------------+
| Further information on the Offer |
| Hawkpoint, which is authorised and regulated by the Financial Services |
| Authority in the United Kingdom, is acting exclusively for Consort Medical |
| and no one else in connection with the Offer and will not be responsible |
| to anyone other than Consort Medical for providing the protections |
| afforded to clients of Hawkpoint nor for providing advice in relation to |
| the Offer or to the matters referred to herein. |
| This announcement is not and does not form any part of an offer to sell or |
| an invitation to purchase any securities or the solicitation of any offer |
| to sell in any jurisdiction pursuant to the Offer or otherwise. The Offer |
| will be carried out solely through the Offer Document and the Form of |
| Acceptance, which contain the full terms and conditions of the Offer |
| (including details of how the Offer may be accepted). Any acceptance or |
| other response to the Offer should be made only on the basis of the |
| information in the Offer Document and the Form of Acceptance. The Medical |
| House Shareholders are strongly advised to read carefully the formal |
| documentation in relation to the Offer. |
| The availability of the Offer (including the Loan Notes Alternative) to |
| persons who are not resident in and citizens of the United Kingdom may be |
| affected by the laws of the relevant jurisdictions in which they are |
| located. Such persons should inform themselves about, and observe, any |
| applicable legal or regulatory requirements of their jurisdictions. |
| The release, publication or distribution of this announcement in |
| jurisdictions other than the UK may be restricted by law and therefore any |
| persons who are subject to the laws of any jurisdiction other than the UK |
| should inform themselves about, and observe, any applicable requirements. |
| Any failure to comply with the applicable requirements may constitute a |
| violation of the securities laws of any such jurisdiction. |
| The Offer (including the Loan Notes Alternative) is not being made, |
| directly or indirectly, in or into a Restricted Jurisdiction or any other |
| jurisdiction where to do the same would constitute a violation of the |
| relevant laws of such jurisdiction. Copies of this announcement and/or the |
| Offer Document and/or any other related document are not being, and must |
| not be, directly or indirectly, mailed or otherwise forwarded, distributed |
| or sent in, into or from a Restricted Jurisdiction or any other |
| jurisdiction where to do the same would constitute a violation of the |
| relevant laws of such jurisdiction and persons receiving this announcement |
| and/or the Offer Document and/or any other related document (including |
| custodians, nominees and trustees) must not mail or otherwise distribute |
| or send them in, into or from such jurisdictions as doing so may |
| invalidate any purported acceptance of the Offer. |
| This announcement has been prepared for the purposes of complying with the |
| Code and English law and the information disclosed has been prepared in |
| accordance with the Code and English law disclosure requirements, format |
| and style, all of which may differ from those in jurisdictions outside of |
| England. |
| A copy of this Announcement will be published on the Consort Medical |
| website: www.consortmedical.com |
| |
+------------------+---------------------------------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
OUPUKUWRKRRAAAA
Medical House (LSE:MLH)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Medical House (LSE:MLH)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
